Flavin adenine dinucleotide
(Synonyms: 黄素腺嘌呤二核苷酸; FAD) 目录号 : GC13392
Flavin adenine dinucleotide(黄素腺嘌呤二核苷酸,FAD)是一种重要的氧化还原辅因子,广泛参与细胞的能量代谢和电子传递过程。
Cas No.:146-14-5
Sample solution is provided at 25 µL, 10mM.
Flavin adenine dinucleotide (FAD) is an important redox cofactor that is widely involved in cellular energy metabolism and electron transfer processes[1, 2]. Flavin adenine dinucleotide is composed of riboflavin (vitamin B2) and adenosine monophosphate (AMP) connected by a phosphate group. It can be reversibly converted between FAD (oxidized state) and FADH2 (reduced state) and participates in the double electron transfer reaction[3]. Flavin adenine dinucleotide can cause vasodilation in the rat mesenteric and hindlimb vascular beds[4].
In vitro, treatment of HeLa cells with Flavin adenine dinucleotide (12.5μM) under blue light irradiation for 2h significantly increased the generation of intracellular reactive oxygen species (ROS)[5].
In vivo, Flavin adenine dinucleotide (0.1mg/kg) was intraperitoneally injected into spontaneously hypertensive (SHR) rats for 8 weeks, which improved vascular remodeling in the rats. The arrangement of aortic vascular fibers in the hypertensive state was improved, the medial layer was thinned, and the elastic fiber structure of the intima returned to normal[6]. Flavin adenine dinucleotide (2mg/kg) was administered intravenously to treat dogs with chlorpromazine (CPZ)-induced ventricular arrhythmias and significantly offset the CPZ-induced decrease in ventricular fibrillation threshold (VFT)[7].
References:
[1] Barile M, Giancaspero T A, Leone P, et al. Riboflavin transport and metabolism in humans[J]. Journal of inherited metabolic disease, 2016, 39(4): 545-557.
[2] Palmieri F, Monné M, Fiermonte G, et al. Mitochondrial transport and metabolism of the vitamin B‐derived cofactors thiamine pyrophosphate, coenzyme A, FAD and NAD+, and related diseases: A review[J]. IUBMB life, 2022, 74(7): 592-617.
[3] Foroutannejad S. Single-molecule Analysis of the Role of Flavin Adenine Dinulcleotide in the Conformational Landscapes of Drosophila Cryptochrome[M]. Georgetown University, 2020.
[4] Hashmi-Hill M P, Sandock K, Bates J N, et al. Flavin adenine dinucleotide may release preformed stores of nitrosyl factors from the vascular endothelium of conscious rats[J]. Journal of cardiovascular pharmacology, 2007, 50(2): 142-154.
[5] Yang M Y, Chang C J, Chen L Y. Blue light induced reactive oxygen species from flavin mononucleotide and flavin adenine dinucleotide on lethality of HeLa cells[J]. Journal of Photochemistry and Photobiology B: Biology, 2017, 173: 325-332.
[6] Zhong X, Ma Z, Su Y, et al. Flavin adenine dinucleotide ameliorates hypertensive vascular remodeling via activating short chain acyl-CoA dehydrogenase[J]. Life sciences, 2020, 258: 118156.
[7] SUGWYAMA S, Ozawa T. Protection of chlorpromazine-induced arrhythmia by flavin-adenine-dinucleotide in canine heart[J]. Japanese Heart Journal, 1979, 20(5): 657-665.
Flavin adenine dinucleotide(黄素腺嘌呤二核苷酸,FAD)是一种重要的氧化还原辅因子,广泛参与细胞的能量代谢和电子传递过程[1, 2]。Flavin adenine dinucleotide由核黄素(维生素B2)、腺苷一磷酸(AMP)通过磷酸基团连接而成,能够在FAD(氧化态)和FADH2(还原态)之间可逆转化,参与双电子转移反应[3]。Flavin adenine dinucleotide能够引起大鼠肠系膜和后肢血管床中的血管舒张[4]。
在体外,Flavin adenine dinucleotide(12.5μM)处理蓝光照射条件下的HeLa细胞2h,显著增加了细胞内活性氧(ROS)的生成[5]。
在体内,Flavin adenine dinucleotide(0.1mg/kg)通过腹腔注射治疗自发性高血压(SHR)大鼠8周,改善了大鼠的血管重塑,高血压状态下的主动脉血管纤维排列改善,中膜变薄,内膜弹性纤维结构恢复正常[6]。Flavin adenine dinucleotide(2mg/kg)通过静脉注射治疗氯丙嗪(CPZ)诱发室性心律失常的犬,显著抵消了氯丙嗪引起的室颤阈值(VFT)降低[7]。
Cell experiment [1]: | |
Cell lines | HeLa cells |
Preparation Method | HeLa cells (5×105 cells/ml) were maintained in different conditions (negative control, 12.5μM Flavin mononucleotide (FMN)/Flavin adenine dinucleotide (FAD), blue light and FMN/FAD that was exposed to irradiation) for 2h and cellular ROS that was produced during the experiment assayed using a Total ROS detection kit. |
Reaction Conditions | 12.5μM; 2h |
Applications | The intracellular ROS levels are not changed significantly by an individual treatment with FMN, Flavin adenine dinucleotide (FAD) or blue light irradiation. However, the FMN/FAD treatment with blue light irradiation doubles ROS production in HeLa cells. |
Animal experiment [2]: | |
Animal models | Wistar Rats、Spontaneously Hypertensive Rats |
Preparation Method | 12-week-old male Wistar rats and SHRs (Spontaneously Hypertensive Rats) were used as an hypertension-induced vascular remodeling model or control, which were treated by Flavin adenine dinucleotide (FAD) at dose of 0.1mg/kg/day or saline for 8 weeks. Animals were randomly assigned to the following groups: Wistar+NS, Wistar+FAD, SHR+NS, SHR+FAD, there were 9 rats in each group. The rats were anesthetized by an intraperitoneal injection of sodium pentobarbital (45mg/kg), and euthanized under anaesthesia by exsanguination and thorax was opened. The hearts were infused with pre-chilled saline to separate the complete aorta. The aorta were excised in the length of 0.5cm, which were near the coronary artery and placed into 4% neutral buffered formalin for histopathology. |
Dosage form | 0.1mg/kg/day; 8 weeks; i.p. |
Applications | Flavin adenine dinucleotide improves vascular remodeling in SHR. After Flavin adenine dinucleotide administration, the aortic vascular fiber arrangement in the hypertensive state improved, the media thinned, and the intimal elastin fiber structure returned to normal. |
References: |
Cas No. | 146-14-5 | SDF | |
别名 | 黄素腺嘌呤二核苷酸; FAD | ||
Canonical SMILES | CC1=CC(N=C(C(O)=N2)C3=NC2=O)=C(N3C[C@@](O)([H])[C@@](O)([H])[C@@](O)([H])COP(O)(OP(O)(OC[C@](O4)([H])[C@](O)([H])[C@](O)([H])[C@]4([H])N5C=NC(C5=NC=N6)=C6N)=O)=O)C=C1C | ||
分子式 | C27H33P2N9O15 | 分子量 | 785.55 |
溶解度 | ≥ 196.5mg/mL in Water | 储存条件 | Store at -20°C,protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 1.273 mL | 6.365 mL | 12.7299 mL |
5 mM | 0.2546 mL | 1.273 mL | 2.546 mL |
10 mM | 0.1273 mL | 0.6365 mL | 1.273 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet